Rite Aid Pharmacy 04363 | |
753 S Grove St, Ypsilanti, Michigan 48198 | |
(734) 482-7430 |
Name | Rite Aid Pharmacy 04363 |
---|---|
Organization Name | Perry Drug Stores Inc And Subsidiaries |
Location | 753 S Grove St, Ypsilanti, Michigan 48198 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Phone | (734) 482-7430 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The second-most common type of breast cancer is a very different disease than the most common and appears to be a good candidate for a personalized approach to treatment, according to a multidisciplinary team led by University of Pittsburgh Cancer Institute (UPCI) scientists.
Today's headlines include various reports from the campaign trail as well as the latest news about current meningitis outbreak.
ATS Medical, Inc. today announced that its shareholders approved Medtronic, Inc.'s acquisition of ATS Medical for $4.00 per share in cash for each share of ATS Medical stock, which per share amount is subject to decrease in the limited circumstances described in the Agreement and Plan of Merger, dated April 28, 2010, between ATS Medical, Inc., Medtronic, Inc. and Pilgrim Merger Corporation.
Allergan, Inc. has announced the U.S. Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) voted unanimously (9-0) to recommend that the FDA approve LATISSE (bimatoprost solution 0.03%) as a treatment for hypotrichosis (or reduced amount of hair) of the eyelashes.
› Verified 3 days ago
NPI Number | 1326157850 |
Organization Name | PERRY DRUG STORES INC AND SUBSIDIARIES |
Doing Business As | RITE AID PHARMACY 04363 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 753 South Grove Street, Ypsilanti, MI 48198 |
Phone Number | 734-482-7430 |
News Archive
The second-most common type of breast cancer is a very different disease than the most common and appears to be a good candidate for a personalized approach to treatment, according to a multidisciplinary team led by University of Pittsburgh Cancer Institute (UPCI) scientists.
Today's headlines include various reports from the campaign trail as well as the latest news about current meningitis outbreak.
ATS Medical, Inc. today announced that its shareholders approved Medtronic, Inc.'s acquisition of ATS Medical for $4.00 per share in cash for each share of ATS Medical stock, which per share amount is subject to decrease in the limited circumstances described in the Agreement and Plan of Merger, dated April 28, 2010, between ATS Medical, Inc., Medtronic, Inc. and Pilgrim Merger Corporation.
Allergan, Inc. has announced the U.S. Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) voted unanimously (9-0) to recommend that the FDA approve LATISSE (bimatoprost solution 0.03%) as a treatment for hypotrichosis (or reduced amount of hair) of the eyelashes.
› Verified 3 days ago
News Archive
The second-most common type of breast cancer is a very different disease than the most common and appears to be a good candidate for a personalized approach to treatment, according to a multidisciplinary team led by University of Pittsburgh Cancer Institute (UPCI) scientists.
Today's headlines include various reports from the campaign trail as well as the latest news about current meningitis outbreak.
ATS Medical, Inc. today announced that its shareholders approved Medtronic, Inc.'s acquisition of ATS Medical for $4.00 per share in cash for each share of ATS Medical stock, which per share amount is subject to decrease in the limited circumstances described in the Agreement and Plan of Merger, dated April 28, 2010, between ATS Medical, Inc., Medtronic, Inc. and Pilgrim Merger Corporation.
Allergan, Inc. has announced the U.S. Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) voted unanimously (9-0) to recommend that the FDA approve LATISSE (bimatoprost solution 0.03%) as a treatment for hypotrichosis (or reduced amount of hair) of the eyelashes.
› Verified 3 days ago
Rite Aid Pharmacy 04363 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 753 S Grove St, Ypsilanti, Michigan 48198 Phone: (734) 482-7430 | |
Cvs Pharmacy #16629 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3749 Carpenter Rd, Ypsilanti, Michigan 48197 Phone: (734) 975-4675 | |
Cvs Pharmacy #08165 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2151 Washtenaw Rd, Ypsilanti, Michigan 48197 Phone: (734) 483-8900 | |
Cvs Pharmacy # 01758 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5408 Whittaker Rd, Ypsilanti, Michigan 48197 Phone: (734) 481-3381 | |
Cvs Pharmacy #08083 Type: Pharmacy Location: 3090 Carpenter Rd, Ypsilanti, Michigan 48197 Phone: (734) 973-7402 |